A new form of CAR T kills leukemia, multiple myeloma, and sarcoma in mice, opening the door to a future off-the-shelf cancer treatment without chemotherapy.

UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, ...

Maria Carolina Florian explores aging and research on the hematopoietic system, particularly focusing on hematopoietic stem cells (HSCs) ...

There are a number of companies, including Aspen, advancing cell therapies for Parkinson’s disease.

Operator: Greetings, and welcome to Longeveron 2025 Full Year Financial Results and Business Update. [Operator Instructions] ...

Tissue Engineering (TE) strategies combining stem cells, biomaterial scaffolds, and biochemical/physical cues have emerged as promising approaches for the repair/replacement of injured tissues and ...

Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival rates have steadily declined over the last few decades.

Around 200 million animals are used in lab research around the world each year. Organoids may one day replace them.

Commercialization ready compound supports a new method of generating highly functional human CAR-T cells for treating infectious diseases and cancer In experimental models, human CAR-T cells ...

Labware for 3D cell culture, low-bind labware, and glycan analysis kits are designed to accelerate life science ...

In Japanese, the word “shinobi” evokes the ninja — blending into the background, unseen. Today, that same idea is inspiring a breakthrough in regenerative medicine.